Maverick Biomaterials is continuing to advance its IP portfolio with regard to 3 Dimensional (3D) fixation of specifically sourced raw pericardium from it supplier Maverick Biosciences.
Recent production for a range of global clients has been well received, with Maverick Biomaterials defining a number of improvements available as production volumes increase.
Maverick has been working with a number of start-up clients to resolve their need for "backroom" processing activities to be undertaken as an outsourced function so as to reduce their infrastructural investment and provide them more time and focus on key objectives....
After completion of a number of validation shipments Maverick New Zealand has commenced ongoing production of device tissues this month against a clients need for a dual sourced supply chain to meet regulatory requirements, and board directives to manage disease risk....
Maverick has this week, drafted a project plan for the production and selection of sized porcine leaflets, for fixation in Australia, prior to export. Expanding upon its success in the bovine and equine tissues area, Maverick has built a project plan for a customised...